Skip to content
Agentic OS
Menu

Intelligence / Healthtech / FDA 510(k) Clearances / Anika Therapeutics, Inc.

Approvalsdevice cleared2 Sept 2026

Anika Therapeutics, Inc.

2 Sept 2026: Device cleared · HYALOMATRIX. Recorded in the openFDA device 510(k) data.

View the source record

Decided
2 Sept 2026
Device
HYALOMATRIX
Specialty
Unknown
Country
United States
Location
Beford, MA
Clearance type
Traditional
510(k) number
K261311
Submitted
2026-04-21
What this signal means

A clearance starts commercialisation: distribution, reimbursement, software and sales hires.

  1. 268 added in the 30 days to 9 Nov 2026.
  2. Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS

Find the decision makers at Anika Therapeutics, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for Anika Therapeutics, Inc. in our registers.

More in Unknown

FDA 510(k) Clearances

See all

Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.